Table 2.
Osteosarcoma PDX-derived cell line in vivo intravenous study summary table.
| OS152 | OS742 | OS525 | OS052 | OS526 | OS186 | OS384 | OS457 | ||
|---|---|---|---|---|---|---|---|---|---|
| # Mice Total [# Studies] | 5 [2] | 6 [1] | 6 [2] | 5 [2] | 5 [2] | 6 [2] | 6 [3] | 5 [1] | |
| Endpoint (avg days) | 53 | 55 | 80 | 85 | 140 | 160 | 168 | 168 | |
| Endpoint Decision with CS, if Applicable | BLI, CS | BLI, CS | CS | BLI | BLI | max | max | max | |
| abd mass | low BCS, gait | paralysis | N/A | N/A | N/A | N/A | N/A | ||
| Metastatic Sites (%) | Lung | 100 | 100 | 67 | 100 | 100 | N/A | 100 | N/A |
| Bone | 20 | 33 | 100 | 20 | 0 | — | 0 | — | |
| Liver | 60 | 100 | 67 | 0 | 0 | — | 0 | — | |
| Other | 20 | 33 | 33 | 20 | 0 | — | 0 | — | |
Abbreviations: abd, abdominal; avg, average; BCS, body condition score; CS, clinical signs.